Detection of bone metastases in routine follow-up after treatment for primary breast cancer

Breast Cancer

Volumn 10, Issue 4, 2003, Pages 335-340

  Sato, Nobuaki ^a   Hino, Masato ^a   Sano, Muneaki ^a  

^a NIIGATA CANCER CENTER HOSPITAL   (Japan)

Author keywords

Bone metastases; Bone scan; Breast cancer; Follow up; Recurrence; Serum tumor marker

Indexed keywords

TUMOR MARKER;

ARTICLE; BLOOD; BONE TUMOR; BREAST TUMOR; FEMALE; FOLLOW UP; HUMAN; MAMMOGRAPHY; METASTASIS; MORTALITY; PATHOLOGY; SURVIVAL; TUMOR RECURRENCE;

BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 1542651177     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967654     Document Type: Article

References (24)

1. Jager W: The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements. Eur J Cancer Prey 2:133-139, 1993.
2. McQuellon RP, Muss HB, Hoffmann SL, Russell G, Craven B, Yellen SB: Patient preference for treatment of metastatic breast cancer: A study of women with early-stage breast cancer. J Clin Oncol 13:858-868, 1995.
3. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 271:1587-1592, 1994.
4. Holli K, Hakama M: Effectiveness of routine and spontaneous follow-up visits for breast cancer. Eur J Cancer Clin Onco1 25:251-254, 1989. (Pubitemid 19054828)
5. Rutgers EJ, van Slooten EA, Kluck HM: Follow-up after treatment of primary breast cancer. Br J Surg 76:187-190, 1989. (Pubitemid 19057023)
6. Temple LK, Wang EE, McLeod RS: Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care. CMAJ 161:1001-1008, 1999. (Pubitemid 29495501)
7. 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865-1878, 2001.
8. Chan DW, Beveridge RA, Muss H, Fritsche HA, Hortobagyi G, Theriault R, Kiang D, Kennedy BJ, Evelegh M: Use of Truquant BR Radioimmunoassay for Early Detection of Breast Cancer Recurrence in Patients With Stage II and Stage III Disease. J Clin Oncol 15:2322-2328, 1997. (Pubitemid 27251134)
9. Holmes FA, Buzdar AU, Kau SW, et al: Combinedmodality approach for patients with isolated recurrence of breast cancer (IV-NED): The M.D. Anderson experience. Breast Disease 7:7-20, 1994. (Pubitemid 24010824)
10. Nieto Y, Nawaz S, Jones RB, Shapall EJ, Cagnoni PJ, McSweeney PA, Baron A, Razook C, Matthes S, Bearman SI: Prognostic model for relapse after highdose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer. J Clin Onco1 20:707-718, 2002. (Pubitemid 34111378)
11. Hortobagyi GN: Can We Cure Limited Metastatic Breast Cancer? J Clin Onco1 20:620-623, 2002. (Pubitemid 34111365)
12. te Boekhorst DS, Peer NG, van der Sluis RF, Wobbes T, Ruers TJ: Periodic follow-up after breast cancer and the effect on survival. Eur J Surg 167:490-496, 2001. (Pubitemid 32783752)
13. Coleman RE, Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer 55:61-66, 1987. (Pubitemid 17234155)
14. Galasko, CSB: The anatomy and pathways of skeletal metastases. In: Weiss L and Gilbert HA eds, Bone Metastasis, p49, G.K. Hall, Boston.
15. Sobin LH, Wittekind Ch eds: TNM classification of Malignant Tumours, 5th ed, New York, Wiley-Liss, 1997.
16. Narita T, Funahashi H, Kontani K, Kanngai R: NCCST-439. Drugs of the Future 19:1084-1087, 1994.
17. Crippa F, Bombardieri E, Seregni E, Castellani MR, Gasparini M, Maffioli L, Pizzichetta M, Buraggi GL: Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer. J Nucl Biol Med 36:52-55, 1992.
18. Joseph E, Hyacinthe M, Lyman GH, Busch C, Demps L, Reintgen DS, Cox CE: Evaluation of an Intensive Strategy for Follow-up and Surveillance of Primary Breast Cancer. Ann Surg Oncol 5:522-528, 1998. (Pubitemid 28421752)
19. Del Turco MR, Palli D, Carddi A, Ciatto S, Pacini P, Ditante V: Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer-A Randomized Trial. JAMA 271:1593-1597, 1994. (Pubitemid 24155619)
20. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU: Long-term follow-up of patients with CR following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14:2197-2205, 1996. (Pubitemid 26264869)
21. Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, Wheeler H, Simeone JF, Seaman JJ, Knight RD, Heffernan M, Mellars K, Reitsma DJ: Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol 16:2038-2044, 1998. (Pubitemid 28265038)
22. Tu SM, Millikan RE, Mengistu B, Delpassand ES, Amato RJ, Pagliaro LC, Daliani D, Papandreou CN, Smith TL, Kim J, Podoloff DA, Logothetis CJ: Bonetargeted therapy for advanced androgen-independent carcinoma of the prostate: a randomized phase II trial. Lancet 357:336-341, 2001. (Pubitemid 32128538)
23. Recommended breast cancer surveillance guidelines. American Society of Clinical Oncology. J Clin Oncol 15:2149-2156, 1997.
24. Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel VG 3rd, Somerfield MR: American Society of Clinical Oncology 1998 Updated of Recommended Breast Cancer Surveillance Guidelines. J Clin Oncol 17:1080-1082, 1999. (Pubitemid 29109342)